Novartis Archives

Healthcare Industry News Weekly Wrap-Up: May 5, 2022

// Biotech and Pharma Therapeutics Astellas keeps the big buyouts rolling, inking $5.9B Iveric takeover ahead of FDA eye disease ruling May 1, 2023 / Astella Pharma / Iveric bio / Mergers and Acquisitions / Eye Disease The multibillion-dollar biotech...

May 5, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 28, 2023

// Biotech and Pharma Therapeutics VBI Vaccines pares down pipeline and staff to focus on hepatitis B programs April 4, 2023 / VBI Vaccines / Layoffs / Hepatitis B / Covid-19 The company will zero in on approved hepatitis B...

April 28, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 21, 2023

April 21, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 7, 2023

April 7, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 31, 2023

// Biotech and Pharma Therapeutics AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug March 28, 2023 / AbbVie / CytomX Therapeutics / Antibody Drug Conjugates / Emerging Biopharma AbbVie has ditched its pact...

March 31, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: March 24, 2023

// Biotech and Pharma Therapeutics Novo Nordisk, Eli Lilly replenish Type 2 diabetes stars Ozempic, Mounjaro after off-label weight-loss boom March 20, 2023 / Novo Nordisk / Ozempic / Wegovy / Eli Lilly Ozempic, which has been in short supply...

March 24, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 17, 2023

// Biotech and Pharma Therapeutics Faced with safety issues over inflammation drug, AstraZeneca spinout Aristea closes shop February 10, 2023 / Biotech closure / Inflammation Things seemed to be going well for Aristea as recently as last November, with the...

February 17, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 3, 2023

// Biotech and Pharma Therapeutics Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug January 31, 2023 / Humira / Amgen / AbbieVie / New Drug Amgen’s drug, a so-called biosimilar named Amjevita, is...

February 3, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 20, 2023

// Biotech and Pharma Therapeutics AbbVie, Novartis and more win national coverage in China even as Pfizer’s Paxlovid gets left out January 18, 2023 / China / Drug Reimbursement / Drug Prices / Pfizer Once again, biopharma companies offered hefty...

January 20, 2023

Weekly Wrap-Up

Pharma Industry News Weekly Recap: January 6, 2023

// Biotech and Pharma Therapeutics Lilly, seeking better CNS gene therapies, pays $55M to join AbbVie on AAV specialist’s list of partners January 4, 2023 / Emerging / Biopharma / Eli Lilly / Capsids / Biotherapeutics Eli Lilly has once...

January 6, 2023

1 2 3 4 5

Tag: Novartis